Research and Development

Showing 15 posts of 9573 posts found.

gamidi_cell_logo

Novartis invests further $15m into Gamida Cell

October 13, 2015 Research and Development, Sales and Marketing Gamida Cell, Novartis, pharma mergers and acquisitions

Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …
s_oschmann_2015

Stefan Oschmann promoted to top job at Merck KGaA

October 13, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA, Stefan Oschmann

Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …
oma_nice

NICE launches new service to speed NHS adoption of health technologies

October 13, 2015 Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, OMA, market access, office for market access

NICE is introducing a new service, the Office for Market Access (OMA), to work with industry to speed up NHS …
berg_niven_narain

Berg interview: artificial intelligence and big data join the war on disease

October 13, 2015 Medical Communications, Research and Development AI, Berg, Big Data, genomics

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …
abpi_logo

Health professionals back transparency of their dealings with pharma

October 12, 2015 Research and Development, Sales and Marketing ABPI, transparency

The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies …
think_big_on_genomics_research

Time for pharma to think big on genomics research

October 12, 2015 Research and Development Sir John Chisholm, genomics

Sir John Chisholm, executive chair of Genomics England, is very clear about what the project he is overseeing is – …
biogen_logo

Biogen reports on Tecfidera multiple sclerosis clinical trials

October 9, 2015 Research and Development

Biogen has presented data demonstrating the efficacy and safety of Tecfidera (dimethyl fumarate) across a broad range of people with …
sativex

Almirall presents new data on cannabinoid-based MS treatment

October 9, 2015 Research and Development Almirall, multiple sclerosis

Almirall has presented new clinical evidences of Sativex, the only medicine derived from cannabinoids to treat spasticity symptoms in MS, …
money_pills

Oncology groups and doctors fight for lower-priced cancer treatments

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing

Oncology groups such as the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) are working …
merckincweb2

Merck announces positive Elbasvir/Grazoprevir trial results

October 9, 2015 Research and Development

Merck has announced the publication of results from C-SURFER, the first Phase III clinical trial to investigate an all-oral, ribavirin-free …
astrazeneca_plaque

AstraZeneca’s Moventig now available through NHS

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, moventig

AstraZeneca has announced that Moventig (naloxegol) has been made available for adult patients with opioid-induced constipation (OIC) in England and …
bronchial_thermoplasty

Taking on IFP, COPD and severe asthma: ERS 2015 roundup

October 9, 2015 Medical Communications, Research and Development

Leading pharmaceutical companies, physicians, healthcare professionals, scientists, respiratory experts, and of course the media, including Pharmafocus, gathered in Amsterdam at the …
Genentech logo

Positive late-stage results for Genentech’s ocrelizumab in different forms of MS

October 8, 2015 Research and Development ECTRIMS, Genentech, MS, Roche, multiple sclerosis, ocrelizumab

Roche’s biotech arm Genentech has presented ‘transformative’ data at an international multiple sclerosis conference on its investigational drug ocrelizumab. Ocrelizumab …
obesity

Innovative pipeline can transform obesity treatment, says GBI Research

October 8, 2015 Research and Development obesity

While the current obesity treatment market has a high level of unmet need, the therapeutic landscape could be transformed by …
troponin_blood_test

Simple blood test can accurately predict imminent heart attacks

October 8, 2015 Research and Development NHS, heart attack

A simple blood test which predicts whether a patient suffering chest pains will have a heart attack has the potential to save …
The Gateway to Local Adoption Series

Latest content